ROMANO, GABRIELE
ROMANO, GABRIELE
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers
2020 Lavitrano, M; Ianzano, L; Bonomo, S; Cialdella, A; Cerrito, M; Pisano, F; Missaglia, C; Giovannoni, R; Romano, G; Mclean, C; Voest, E; D'Amato, F; Noli, B; Ferri, G; Agostini, M; Pucciarelli, S; Helin, K; Leone, B; Canzonieri, V; Grassilli, E
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype
2019 Sala, L; Cirillo, G; Riva, G; Romano, G; Giussani, C; Cialdella, A; Todisco, A; Virtuoso, A; Cerrito, M; Bentivegna, A; Grassilli, E; Ardizzoia, A; Bonoldi, E; Giovannoni, R; Papa, M; Lavitrano, M
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice
2018 Romano, G; Reggi, S; Kutryb-Zajac, B; Facoetti, A; Chisci, E; Pettinato, M; Giuffrè, M; Vecchio, F; Leoni, S; De Giorgi, M; Avezza, F; Cadamuro, M; Crippa, L; Leone, B; Lavitrano, M; Rivolta, I; Barisani, D; Smolenski, R; Giovannoni, R
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties
2018 Giovannoni, R; Facoetti, A; Chisci, E; Reggi, S; Kutryb-Zajac, B; Bombelli, S; Di Marzo, N; Farina, L; Bianchi, C; Perego, R; Avezza, F; Cadamuro, M; Crippa, L; Lavitrano, M; Bentivegna, A; Leone, B; Rivolta, I; Barisani, D; Smolenski, R; Romano, G
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway
2017 Cilibrasi, C; Riva, G; Romano, G; Cadamuro, M; Bazzoni, R; Butta, V; Paoletta, L; Dalpra', L; Strazzabosco, M; Lavitrano, M; Giovannoni, R; Bentivegna, A
Thyrospheres from B-CPAP Cell Line with BRAF and TERT promoter mutations have Different Functional and Molecular Features than Parental Cells
2017 Caria, P; Pillai, R; Dettori, T; Frau, D; Zavattari, P; Riva, G; Romano, G; Pani, F; Bentivegna, A; Giovannoni, R; Pagni, F; Sogos, V; Vanni, R
Genomic evolution of a human glioma stem cell line in an orthotopic GBM mouse model
2016 Bentivegna, A; Riva, G; Negroni, C; Cilibrasi, C; Bazzoni, R; Redaelli, S; Romano, G; Giovannoni, R; Giussani, C
Glioblastoma multiforme: a multidisciplinary approach to overcome chemoresistance and find new therapeutic strategies
2016 Riva, G; Negroni, C; Cilibrasi, C; Romano, G; Redaelli, S; Giussani, C; Giovannoni, R; Bentivegna, A
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells
2016 Romano, G; Santi, L; Bianco, M; Giuffrè, M; Pettinato, M; Bugarin, C; Garanzini, C; Savarese, L; Leoni, S; Cerrito, M; Leone, B; Gaipa, G; Grassilli, E; Papa, M; Lavitrano, M; Giovannoni, R
A functional biological network centered on XRCC3: A new possible marker of chemoradiotherapy resistance in rectal cancer patients
2015 Agostini, M; Zangrando, A; Pastrello, C; D'Angelo, E; Romano, G; Giovannoni, R; Giordan, M; Maretto, I; Bedin, C; Zanon, C; Digito, M; Esposito, G; Mescoli, C; Lavitrano, M; Rizzolio, F; Jurisica, I; Giordano, A; Pucciarelli, S; Nitti, D
Molecular mechanisms of cancer drug resistance
2015 Romano, G
Combinations of a btk inhibitor and fluorouracil for treating cancers
2014 Cerrito, M; Giovannoni, R; Grassilli, E; Lavitrano, M; Masiero, L; Pisano, F; Romano, G
Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
2013 Grassilli, E; Narloch, R; Federzoni, E; Ianzano, L; Pisano, F; Giovannoni, R; Romano, G; Masiero, L; Leone, B; Bonin, S; Donada, M; Stanta, G; Helin, K; Lavitrano, M
Pharmaceutical kit for use in the treatment of colon and colorectal cancer
2013 Cerrito, M; Giovannoni, R; Grassilli, E; Lavitrano, M; Masiero, L; Pisano, F; Romano, G